In a significant move to overhaul the nation’s approach to drug policy, the Department of Justice (DOJ) and the Dangerous Drugs Board (DDB) have initiated a thorough review of Republic Act 9165, known as the Dangerous Drugs Act of 2002. This review, which kicked off on February 11, 2025, is in response to President Ferdinand R. Marcos Jr.’s call for a more holistic strategy to tackle the drug issue, emphasizing both enforcement and rehabilitation efforts.
The review process is being led by DOJ Undersecretary Jesse Hermogenes Andres and DDB Secretary Oscar Valenzuela, who convened for the first Pre-Writeshop Activity of the year. The initiative aims to adopt a ‘whole-of-government approach’ that not only focuses on law enforcement but also integrates social services and various interventions, such as community-based rehabilitation, educational programs, and reintegration efforts for those affected by drug use.
This collaborative effort includes participation from non-government organizations, civil society groups, the University of the Philippines’ Institute of Human Rights, and international bodies like the United Nations Office on Drugs and Crime (UNODC). The review process is designed to be highly consultative, ensuring that the insights and recommendations from the 1st Drug Policy and Law Reform Summit held in July 2024 are taken into account.
Undersecretary Andres emphasized the importance of incorporating the views of subject matter experts, including advocates for human rights and health. The ultimate goal of this review is to produce a revised bill that amends RA 9165, ensuring it is grounded in evidence, supported by comprehensive data and statistics, and aligned with international standards and best practices.